clorazepate dipotassium

Generic: clorazepate dipotassium

Labeler: apotex corp.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name clorazepate dipotassium
Generic Name clorazepate dipotassium
Labeler apotex corp.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

clorazepate dipotassium 3.75 mg/mg

Manufacturer
Apotex Corp.

Identifiers & Regulatory

Product NDC 60505-4754
Product ID 60505-4754_ab0eda3d-5823-2483-7ecc-aa22d0a9e25f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA215566
DEA Schedule civ
Listing Expiration 2026-12-31
Marketing Start 2022-09-22

Pharmacologic Class

Classes
benzodiazepine [epc] benzodiazepines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 605054754
Hyphenated Format 60505-4754

Supplemental Identifiers

RxCUI
197464 197465 197466
UPC
0360505475650 0360505475612
UNII
63FN7G03XY

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name clorazepate dipotassium (source: ndc)
Generic Name clorazepate dipotassium (source: ndc)
Application Number ANDA215566 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 3.75 mg/mg
source: ndc
Packaging
  • 100 mg in 1 BOTTLE (60505-4754-1)
source: ndc

Packages (1)

Ingredients (1)

clorazepate dipotassium (3.75 mg/mg)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ab0eda3d-5823-2483-7ecc-aa22d0a9e25f", "openfda": {"upc": ["0360505475650", "0360505475612"], "unii": ["63FN7G03XY"], "rxcui": ["197464", "197465", "197466"], "spl_set_id": ["6e07efe5-29b6-6d1e-661a-f696c4b17f43"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 mg in 1 BOTTLE (60505-4754-1)", "package_ndc": "60505-4754-1", "marketing_start_date": "20220922"}], "brand_name": "Clorazepate Dipotassium", "product_id": "60505-4754_ab0eda3d-5823-2483-7ecc-aa22d0a9e25f", "dosage_form": "TABLET", "pharm_class": ["Benzodiazepine [EPC]", "Benzodiazepines [CS]"], "product_ndc": "60505-4754", "dea_schedule": "CIV", "generic_name": "Clorazepate Dipotassium", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Clorazepate Dipotassium", "active_ingredients": [{"name": "CLORAZEPATE DIPOTASSIUM", "strength": "3.75 mg/mg"}], "application_number": "ANDA215566", "marketing_category": "ANDA", "marketing_start_date": "20220922", "listing_expiration_date": "20261231"}